Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis. Alsabani M, Abrams ST, Cheng Z, Morton B, Lane S, Alosaimi S, Yu W, Wang G, Toh CH,
